Oral symptoms and oral health-related quality of life in patients with chronic kidney disease from predialysis to posttransplantation.


Journal

Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115

Informations de publication

Date de publication:
May 2019
Historique:
received: 30 08 2017
accepted: 20 09 2018
pubmed: 3 10 2018
medline: 31 12 2019
entrez: 3 10 2018
Statut: ppublish

Résumé

This prospective follow-up cohort study analyzed chronic kidney disease (CKD) patients' oral symptoms, health habits, and oral health-related quality of life (OHRQoL), from predialysis to posttransplantation. A simplified questionnaire method (Oral Health Quality Score, OHQS), based on these and clinical findings, was constructed and tested for identifying patients in need for referral to a dentist. Fifty-three CKD patients were followed up for a mean of 10.3 years. Clinical oral, radiological, and salivary examination was performed at baseline and posttransplantation. Total Dental Index (TDI) indicating inflammation was calculated. The patients filled out a questionnaire on symptoms, oral hygiene and health care habits, smoking, alcohol use, and medication. General health-related quality of life was assessed with the 15-dimensional (15D) instrument at posttransplantation. Descriptive and analytical methods were used in statistics. OHQS significantly correlated with high TDI (p = 0.017), number of teeth (p = 0.031), and unstimulated salivary flow rate (p = 0.001) in transplanted patients. Number of daily medications showed a negative correlation with the OHQS (r = - 0.30; p = 0.028). The prevalence of oral symptoms was slightly, but not significantly, more common posttransplantation compared with predialysis stage. OHQS identified patients with high oral inflammatory score thus confirming our study hypothesis. Use of OHQS and measuring salivary flow indicate patients at risk for oral diseases. These markers might be easy to use chair-side also by auxiliary personnel.

Identifiants

pubmed: 30276517
doi: 10.1007/s00784-018-2647-z
pii: 10.1007/s00784-018-2647-z
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2207-2213

Subventions

Organisme : Helsingin ja Uudenmaan Sairaanhoitopiiri
ID : TYH2013334

Références

Drugs Aging. 1999 Aug;15(2):103-16
pubmed: 10495070
Ann Med. 2001 Jul;33(5):328-36
pubmed: 11491191
Community Dent Health. 2001 Sep;18(3):138-43
pubmed: 11580088
J Dent Res. 1992 Dec;71(12):1875-80
pubmed: 1452886
Quintessence Int. 2007 Mar;38(3):211-9
pubmed: 17333998
Nutr Metab Cardiovasc Dis. 2007 Dec;17(10):757-62
pubmed: 17606365
Community Dent Oral Epidemiol. 2007 Aug;35 Suppl 1:20-31
pubmed: 17615047
Value Health. 2007 Sep-Oct;10(5):390-7
pubmed: 17888104
Community Dent Oral Epidemiol. 2007 Dec;35(6):401-11
pubmed: 18039281
Am J Kidney Dis. 2008 Jan;51(1):45-52
pubmed: 18155532
J Periodontol. 2008 Feb;79(2):224-31
pubmed: 18251637
BMC Oral Health. 2008 May 15;8:16
pubmed: 18482446
Oral Health Prev Dent. 2008;6(3):209-16
pubmed: 19119575
Med Oral Patol Oral Cir Bucal. 2009 Nov 01;14(11):e573-8
pubmed: 19680207
J Dent Res. 2011 Nov;90(11):1264-70
pubmed: 21422477
Clin Oral Investig. 2012 Apr;16(2):559-63
pubmed: 21455747
Lancet. 2013 Jul 13;382(9887):158-69
pubmed: 23727165
Lancet. 2013 Jul 20;382(9888):260-72
pubmed: 23727169
BMJ. 1989 Mar 25;298(6676):779-81
pubmed: 2496855
Transpl Int. 2014 Nov;27(11):1143-51
pubmed: 24977951
Quintessence Int. 2015 Nov-Dec;46(10):899-907
pubmed: 26345099
Braz Oral Res. 2017 Jan 16;31:e14
pubmed: 28099580
Clin Oral Investig. 2018 Jan;22(1):339-347
pubmed: 28424878
Community Dent Oral Epidemiol. 1997 Aug;25(4):284-90
pubmed: 9332805
Am J Kidney Dis. 1998 Jul;32(1):93-100
pubmed: 9669429

Auteurs

Hellevi Ruokonen (H)

Head and Neck Center, Oral and Maxillofacial Diseases, Helsinki University Hospital and University of Helsinki, P.O.Box 263, Kasarmikatu 11-13, FI-00029 HUS, Helsinki, Finland. hellevi.ruokonen@hus.fi.

Karita Nylund (K)

Head and Neck Center, Oral and Maxillofacial Diseases, Helsinki University Hospital and University of Helsinki, P.O.Box 263, Kasarmikatu 11-13, FI-00029 HUS, Helsinki, Finland.

Jukka H Meurman (JH)

Head and Neck Center, Oral and Maxillofacial Diseases, Helsinki University Hospital and University of Helsinki, P.O.Box 263, Kasarmikatu 11-13, FI-00029 HUS, Helsinki, Finland.

Anna M Heikkinen (AM)

Head and Neck Center, Oral and Maxillofacial Diseases, Helsinki University Hospital and University of Helsinki, P.O.Box 263, Kasarmikatu 11-13, FI-00029 HUS, Helsinki, Finland.

Jussi Furuholm (J)

Head and Neck Center, Oral and Maxillofacial Diseases, Helsinki University Hospital and University of Helsinki, P.O.Box 263, Kasarmikatu 11-13, FI-00029 HUS, Helsinki, Finland.

Timo Sorsa (T)

Head and Neck Center, Oral and Maxillofacial Diseases, Helsinki University Hospital and University of Helsinki, P.O.Box 263, Kasarmikatu 11-13, FI-00029 HUS, Helsinki, Finland.
Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.

Risto Roine (R)

Group Administration, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Social and Health Management, University of Eastern Finland, Kuopio, Finland.

Fernanda Ortiz (F)

Abdominal Center, Nephrology, Helsinki University Hospital, Helsinki, Finland.
Folkhälsan Research Center, Folkhälsan Institute of Genetics, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH